- Home
- What We Do
- Investment Banking
- Transactions
- 2022
- April
- RiteGene_Apr2022
RiteGene Technologies
April 2022
RiteGene Technologies
Exclusive Financial Advisor (Sell side)
RiteGene Technologies
Canaccord Genuity Acts as Exclusive Financial Advisor to RiteGene Technologies on its sale to Bloom Medicinals
Lead Transaction Banker
Deal Team
More like this
RiteGene Technologies
April 2022
RiteGene Technologies
Exclusive Financial Advisor (Sell side)
£8.5m
March 2022
Celadon Pharmaceuticals Plc
Nomad, Financial Adviser and Sole Broker
How can we help?
If you would like to find out more about Canaccord Genuity or any of our services, please get in touch.